CFD
CSTL icon

Creative Financial Designs’s Castle Biosciences CSTL Stock Holding History

Creative Financial Designs’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$4.71K – 1409
2022
Q4 		$4.71K Sell
200
-50
-20% -$1.16K ﹤0.01% 1050
2022
Q3 		$7K Sell
250
-350
-58% -$9.81K ﹤0.01% 955
2022
Q2 		$13K Buy
600
+100
+20% +$2.32K ﹤0.01% 810
2022
Q1 		$22K Hold
500
– – ﹤0.01% 743
2021
Q4 		$21K Hold
500
– – ﹤0.01% 750
2021
Q3 		$33K Sell
500
-1,148
-70% -$80.8K 0.01% 714
2021
Q2 		$121K Hold
1,648
– – 0.02% 406
2021
Q1 		$113K Sell
1,648
-324
-16% -$24.4K 0.02% 391
2020
Q4 		$132K Buy
+1,972
New +$107K 0.03% 326

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Creative Financial Designs's CSTL Position: Q1 2023 in Review

Creative Financial Designs sold out of Castle Biosciences (CSTL) in Q1 2023, closing a stake of 200 shares — an estimated $4.71K sold.

Creative Financial Designs first reported a position in CSTL in Q4 2020 and held it in 9 quarters. The position peaked at $132K in Q4 2020. 148 funds tracked by Wall St. Rank hold CSTL as of Q1 2023.

  • Creative Financial Designs reported no remaining Castle Biosciences position as of Q1 2023 after selling out during the quarter.
  • Creative Financial Designs sold 200 Castle Biosciences shares in Q1 2023, an estimated $4.71K.
  • Creative Financial Designs first reported a position in Castle Biosciences in Q4 2020 and held it in 9 quarters.
  • Creative Financial Designs's Castle Biosciences position peaked at $132K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2023.

Based on Creative Financial Designs's 13F filing for Q1 2023, filed 25 Apr 2023.